EFFECTS OF PRE OR POST-TREATMENT WITH OUABAIN ON THE LYMPHOCYTE POPULATION IN A MURINE MELANOMA MODEL (B16F10)

Favorite this paper
How to cite this paper?
Details
  • Presentation type: IC - Undergraduate Students
  • Track: 8. Drugs and/or Natural Products Therapy
  • Keywords: Ouabain; Lymphocytes; Melanoma (B16F10); Immunoregulation;
  • 1 Universidade Federal Fluminense
  • 2 Universidade Federal do Rio de Janeiro

Please log in to watch the video

Log in
Abstract

INTRODUCTION AND OBJECTIVES: Ouabain (OUA) is a cardiotonic steroid which binds to the α-subunit of Na+K+ATPase and generate an inhibitory effect on the transport activity of this enzyme. Previous studies have already shown its role in the modulation of lymphocyte populations and in antitumour response. Our main objective was to analyse and compare the modulation of lymphocyte populations by the in vivo pre-treatment and post-treatment of melanoma-bearing mice with OUA. MATERIAL AND METHODS: C57BL/6 mice were divided into four groups: control group: animals were injected with 200μL of DMEM medium; ouabain group: animals were intraperitoneally injected with 0.56mg/Kg of OUA diluted in DMEM medium; melanoma group: animals were intraperitonealy injected with DMEM and 10⁶ melanoma cells; melanoma plus ouabain group: animals were intraperitoneally injected with OUA diluted in DMEM medium and 10⁶ melanoma cells. Two protocols were used, a pretreatment protocol, in which OUA was administered before melanoma cells injection and a post-treatment protocol, in which OUA was administered seven days after melanoma cells injection. RESULTS AND CONCLUSION: In the pre-treatment model, our results show that OUA leads to a significant reduction in the absolute number of TCD4+ lymphocytes and in the percentage and absolute number of regulatory T lymphocytes in the spleen of animals with melanoma. B lymphocytes were maintained in animals treated with ouabain. Ouabain also promoted an improvement in the survival of animals with melanoma. In the post-treatment model, there was a reduction in the percentage and absolute number of TCD4+, TCD8+ and B lymphocytes, but there was no reduction in the percentage and absolute number of regulatory T lymphocytes in melanoma-bearing animals treated with ouabain. In this model, no significant difference was observed regarding the survival melanoma-bearing animals treated with ouabain or untreated. These results show that ouabain is an immunomodulator that favored antitumour response in the pre-treatment protocol. However post-tumour administration of ouabain did not affect lymphocyte populations. In conclusion, ouabain acts in a preventive way through the modulation of antitumor response.

Questions (2 topics)

Share your ideas or questions with the authors!

Did you know that the greatest stimulus in scientific and cultural development is curiosity? Leave your questions or suggestions to the author!

Sign in to interact

Have a question or suggestion? Share your feedback with the authors!

Author

Rayane Costa

Boa tarde, Andrea! No contexto do melanoma, a diminuição de células T regulatórias ocasionada pela Ouabaína no modelo de pré-tratamento seria interessante pra melhora da resposta antitumoral.
Em relação a diferença observada na resposta de sobrevivência nos dois protocolos, nosso grupo considerou que a ouabaína não é capaz de reverter o quadro quando administrada depois que o tumor já está estabelecido no animal.

Andrea Claudia Freitas Ferreira

Trabalho muito interessante! Obrigada!

Author

Rayane Costa

Olá Anneliese! Esse protocolo foi estabelecido porque que era necessário um intervalo de tempo para o crescimento tumoral que fosse inferior ao 15º dia, pois era quando os animais começavam a morrer. Um tratamento com ouabaína por um tempo maior, induziria hipertensão nos animais. Consideramos que a ouabaína não consegue exercer seu papel imunomodulador quando administrada após a instalação do tumor.